These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16609363)

  • 1. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
    Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie PI; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO
    Pharmacogenet Genomics; 2006 May; 16(5):321-9. PubMed ID: 16609363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.
    Grant DJ; Hall IJ; Eastmond DA; Jones IM; Bell DA
    Mutat Res; 2004 May; 560(1):1-10. PubMed ID: 15099818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of the UGT1A1*28 variant in HIV-infected individuals in Greece.
    Panagopoulos P; Paraskevis D; Katsarolis I; Sypsa V; Detsika M; Protopapas K; Antoniadou A; Papadopoulos A; Petrikkos G; Hatzakis A
    Int J STD AIDS; 2014 Oct; 25(12):860-5. PubMed ID: 24516079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
    Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
    J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
    Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
    Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
    Zhang D; Chando TJ; Everett DW; Patten CJ; Dehal SS; Humphreys WG
    Drug Metab Dispos; 2005 Nov; 33(11):1729-39. PubMed ID: 16118329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short communication: UGT1A1*28 variant allele is a predictor of severe hyperbilirubinemia in HIV-infected patients on HAART in southern Brazil.
    Turatti L; Sprinz E; Lazzaretti RK; Kuhmmer R; Agnes G; Silveira JM; Basso RP; Pinheiro CA; Silveira MF; de Almeida S; Ribeiro JP; Mattevi VS
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1015-8. PubMed ID: 22050734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.
    Rodríguez-Nóvoa S; Martín-Carbonero L; Barreiro P; González-Pardo G; Jiménez-Nácher I; González-Lahoz J; Soriano V
    AIDS; 2007 Jan; 21(1):41-6. PubMed ID: 17148966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.
    Chen Z; Su D; Ai L; Jiang X; Wu C; Xu Q; Wang X; Fan Z
    Gene; 2014 Nov; 552(1):32-8. PubMed ID: 25200497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers.
    Ferraris L; Viganò O; Peri A; Tarkowski M; Milani G; Bonora S; Adorni F; Gervasoni C; Clementi E; Di Perri G; Galli M; Riva A
    J Antimicrob Chemother; 2012 Sep; 67(9):2236-42. PubMed ID: 22661571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1*28 allele frequency.
    Park WB; Choe PG; Song KH; Jeon JH; Park SW; Kim HB; Kim NJ; Oh MD; Choe KW
    Clin Infect Dis; 2010 Jul; 51(1):101-6. PubMed ID: 20504240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutation analysis of UGT1A1 gene in patients with unconjugated hyperbilirubinemia].
    Sun SC; Zhou ZM; Chen QR; Peng YS; Tu CQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):425-8. PubMed ID: 23926009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
    Rotger M; Taffe P; Bleiber G; Gunthard HF; Furrer H; Vernazza P; Drechsler H; Bernasconi E; Rickenbach M; Telenti A;
    J Infect Dis; 2005 Oct; 192(8):1381-6. PubMed ID: 16170755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia.
    Chaar V; Kéclard L; Diara JP; Leturdu C; Elion J; Krishnamoorthy R; Clayton J; Romana M
    Haematologica; 2005 Feb; 90(2):188-99. PubMed ID: 15710570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between UGT 1A1 Gly71Arg (G71R) polymorphism and neonatal hyperbilirubinemia.
    Prachukthum S; Gamnarai P; Kangsadalampai S
    J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S13-7. PubMed ID: 23964438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
    Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
    Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholars.
    Marinković N; Pasalić D; Grsković B; Ferencak G; Honović L; Rukavina AS
    Coll Antropol; 2008 Sep; 32(3):725-9. PubMed ID: 18982743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.
    Culley CL; Kiang TK; Gilchrist SE; Ensom MH
    Ann Pharmacother; 2013 Apr; 47(4):561-72. PubMed ID: 23548653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
    Takeuchi K; Kobayashi Y; Tamaki S; Ishihara T; Maruo Y; Araki J; Mifuji R; Itani T; Kuroda M; Sato H; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1023-8. PubMed ID: 15304120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal jaundice and bilirubin UDP-glucuronosyl transferase 1A1 gene polymorphism in Turkish patients.
    Babaoglu MO; Yigit S; Aynacioglu AS; Kerb R; Yurdakok M; Bozkurt A
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):377-80. PubMed ID: 16623861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.